European Medicines Agency (EMA) | What's new 中文 关注 孤儿药指定：resecabtagene autoleucel 治疗特发性炎症性肌病，2025/07/18 积极 Orphan designation: resecabtagene autoleucel Treatment of idiopathic inflammatory myopathy, 18/07/2025 Positive ema.europa.eu
